CoChat

Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification

Rosado, Jason, Han, Jiru, Obadia, Thomas, Munro, Jacob, Traore, Zeinabou, Schoffer, Kael, Brewster, Jessica, Bourke, Caitlin, Vinetz, Joseph M., Taylor, Aimee R., White, Michael, Bahlo, Melanie, Gamboa, Dionicia, Mueller, Ivo, Ruybal-Pesántez, Shazia · 2026 · iScience
Cited by 3

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.isci.2026.115799

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 64

  1. Robinson, 2015, Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model, PLoS Med., 12, 10.1371/journal.pmed.1001891 · DOI · Paper page
  2. Gruenberg, 2019, Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs, Sci. Rep., 9, 10.1038/s41598-019-54203-0 · doi:10.1038/s41598-019-54203-0
  3. Kleinecke, 2025, Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages, Nat. Commun., 16, 7192, 10.1038/s41467-025-62357-x · DOI · Paper page
  4. Lerch, 2017, Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections, BMC Genom., 18, 864, 10.1186/s12864-017-4260-y · DOI
  5. Ruybal-Pesántez, 2024, Molecular markers for malaria genetic epidemiology: progress and pitfalls, Trends Parasitol., 40, 147, 10.1016/j.pt.2023.11.006 · DOI · Paper page
  6. Lerch, 2019, Longitudinal tracking and quantification of individual Plasmodium falciparum clones in complex infections, Sci. Rep., 9, 3333, 10.1038/s41598-019-39656-7 · DOI · Paper page
  7. Lin, 2015, Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse, J. Infect. Dis., 212, 999, 10.1093/infdis/jiv142 · DOI
  8. Wamae, 2022, Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 2; peer review: 1 approved, 1 approved with reservations], Wellcome Open Res., 7, 95, 10.12688/wellcomeopenres.17736.2 · doi:10.12688/wellcomeopenres.17736.2
  9. Jones, 2021, Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?, Antimicrob. Agents Chemother., 65, 10.1128/AAC.00437-21 · doi:10.1128/aac.00437-21
  10. He, 2021, Unraveling the Complexity of Imported Malaria Infections by Amplicon Deep Sequencing, Front. Cell. Infect. Microbiol., 11, 10.3389/fcimb.2021.725859 · DOI
  11. Wamae, 2022, Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections, J. Infect. Dis., 226, 920, 10.1093/infdis/jiac144 · DOI · Paper page
  12. Holzschuh, 2024, Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study, PLOS Glob. Public Health, 4, 10.1371/journal.pgph.0002743 · DOI
  13. LaVerriere, 2022, Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: A malaria case study, Mol. Ecol. Resour., 22, 2285, 10.1111/1755-0998.13622 · DOI
  14. Kattenberg, 2023, Molecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Plasmodium falciparum Parasites from Dried Blood Spot DNA Isolates from Peru, Bio. Protoc., 13
  15. Kattenberg, 2023, Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay, Microbiol. Spectr., 11, 10.1128/spectrum.00960-22 · DOI
  16. Talundzic, 2018, Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance, Antimicrob. Agents Chemother., 62, e02474-17, 10.1128/AAC.02474-17 · DOI
  17. Huwe, 2022, Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh, Malar. J., 21, 218, 10.1186/s12936-022-04236-0 · DOI
  18. Wei, 2024, Genetic diversity of Plasmodium vivax population in northeast Myanmar assessed by amplicon sequencing of PvMSP1 and PvMSP3α, Acta Trop., 260, 10.1016/j.actatropica.2024.107461 · DOI
  19. Tapaopong, 2025, Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand, Sci. Rep., 15, 2620, 10.1038/s41598-025-86578-8 · DOI
  20. Reda, 2023, Amplicon deep sequencing of five highly polymorphic markers of Plasmodium falciparum reveals high parasite genetic diversity and moderate population structure in Ethiopia, Malar. J., 22, 376, 10.1186/s12936-023-04814-w · DOI
  21. Tapaopong, 2023, Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand, Infect. Genet. Evol., 113, 10.1016/j.meegid.2023.105467 · doi:10.1016/j.meegid.2023.105467
  22. Holzschuh, 2023, Multiplexed ddPCR-amplicon sequencing reveals isolated Plasmodium falciparum populations amenable to local elimination in Zanzibar, Tanzania, Nat. Commun., 14, 3699, 10.1038/s41467-023-39417-1 · DOI
  23. Kattenberg, 2022, Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales, Front. Cell. Infect. Microbiol., 12, 10.3389/fcimb.2022.953187 · DOI
  24. Kattenberg, 2024, Plasmodium vivax genomic surveillance in the Peruvian Amazon with Pv AmpliSeq assay, PLoS Negl. Trop. Dis., 18, 10.1371/journal.pntd.0011879 · DOI
  25. Popkin-Hall, 2024, High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes, Nat. Commun., 15, 10.1038/s41467-024-54731-y · DOI · Paper page
  26. Hubbard, 2025, PvGAP: Development of a globally-applicable, highly-multiplexed microhaplotype amplicon panel for Plasmodium vivax, medRxiv
  27. James, 2025, Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trial, Front. Malar., 3, 10.3389/fmala.2025.1604498 · DOI
  28. Rosado, 2021, Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009165 · DOI
  29. Han, 2023, AmpSeqR: an R package for amplicon deep sequencing data analysis, F1000Res, 12, 327, 10.12688/f1000research.129581.1 · doi:10.12688/f1000research.129581.1
  30. Mideo, 2013, Ahead of the curve: next generation estimators of drug resistance in malaria infections, Trends Parasitol., 29, 321, 10.1016/j.pt.2013.05.004 · DOI
  31. Barry, 2015, Uncovering the transmission dynamics of Plasmodium vivax using population genetics, Pathog. Glob. Health, 109, 142, 10.1179/2047773215Y.0000000012 · doi:10.1179/2047773215y.0000000012
  32. Gerlovina, 2022, Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections, Genetics, 222, 10.1093/genetics/iyac126 · DOI · Paper page
  33. Foo, 2026, Pv3Rs: Plasmodium vivax relapse, recrudescence, and reinfection statistical genetic inference, Bioinformatics, 42, 10.1093/bioinformatics/btaf643 · DOI · Paper page
  34. Rosas-Aguirre, 2021, Temporal and Microspatial Heterogeneity in Transmission Dynamics of Coendemic Plasmodium vivax and Plasmodium falciparum in Two Rural Cohort Populations in the Peruvian Amazon, J. Infect. Dis., 223, 1466, 10.1093/infdis/jiaa526 · DOI
  35. Manrique, 2019, Microsatellite analysis reveals connectivity among geographically distant transmission zones of Plasmodium vivax in the Peruvian Amazon: A critical barrier to regional malaria elimination, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007876 · DOI
  36. Imwong, 2012, The first Plasmodium vivax relapses of life are usually genetically homologous, J. Infect. Dis., 205, 680, 10.1093/infdis/jir806 · DOI · Paper page
  37. Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, J. Infect. Dis., 195, 934, 10.1086/512242 · DOI · Paper page
  38. Noviyanti, 2022, Hypnozoite depletion in successive Plasmodium vivax relapses, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010648 · DOI
  39. Delgado-Ratto, 2014, Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon, Malar. J., 13, 8, 10.1186/1475-2875-13-8 · doi:10.1186/1475-2875-13-8
  40. Cowell, 2018, Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing, Genome Med., 10, 52, 10.1186/s13073-018-0563-0 · DOI · Paper page
  41. Markus, 2012, Source of homologous parasites in recurrent Plasmodium vivax malaria, J. Infect. Dis., 206, 622, 10.1093/infdis/jis393 · doi:10.1093/infdis/jis393
  42. de Araujo, 2012, Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection, PLoS One, 7, 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
  43. Koepfli, 2013, A large Plasmodium vivax reservoir and little population structure in the South Pacific, PLoS One, 8, 10.1371/journal.pone.0066041 · DOI
  44. Gray, 2013, Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands, Malar. J., 12, 429, 10.1186/1475-2875-12-429 · DOI
  45. Popovici, 2018, Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia, mBio, 9, e01888-17, 10.1128/mBio.01888-17 · DOI
  46. Kho, 2021, Hidden biomass of intact malaria parasites in the human spleen, N. Engl. J. Med., 384, 2067, 10.1056/NEJMc2023884 · doi:10.1056/nejmc2023884
  47. Taylor, 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nat. Commun., 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
  48. Hasugian, 2007, Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria, Clin. Infect. Dis., 44, 1067, 10.1086/512677 · DOI · Paper page
  49. Pukrittayakamee, 2008, Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria, Am. J. Trop. Med. Hyg., 79, 378, 10.4269/ajtmh.2008.79.378 · DOI
  50. Bousema, 2011, Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination, Clin. Microbiol. Rev., 24, 377, 10.1128/CMR.00051-10 · DOI · Paper page
  51. Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0002882 · DOI · Paper page
  52. Markus, 2017, Malaria eradication and the hidden parasite reservoir, Trends Parasitol., 33, 492, 10.1016/j.pt.2017.03.002 · doi:10.1016/j.pt.2017.03.002
  53. Oyola, 2016, Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification, Malar. J., 15, 597, 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
  54. Untergasser, 2012, Primer3--new capabilities and interfaces, Nucleic Acids Res., 40, 10.1093/nar/gks596 · DOI · Paper page
  55. Pagès, 2024, Biostrings: Efficient manipulation of biological strings, R package version, 2, 10
  56. Morgan, 2009, ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data, Bioinformatics, 25, 2607, 10.1093/bioinformatics/btp450 · DOI · Paper page
  57. Carrasco-Escobar, 2017, High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission, Malar. J., 16, 415, 10.1186/s12936-017-2063-x · DOI
  58. Mangold, 2005, Real-time PCR for detection and identification of Plasmodium spp, J. Clin. Microbiol., 43, 2435, 10.1128/JCM.43.5.2435-2440.2005 · DOI · Paper page
  59. Rosanas-Urgell, 2010, Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea, Malar. J., 9, 361, 10.1186/1475-2875-9-361 · DOI · Paper page
  60. Pearson, 2016, Genomic analysis of local variation and recent evolution in Plasmodium vivax, Nat. Genet., 48, 959, 10.1038/ng.3599 · DOI · Paper page
  61. Li, 2009, The Sequence Alignment/Map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
  62. Havryliuk, 2009, A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences, Mem. Inst. Oswaldo Cruz, 104, 67, 10.1590/S0074-02762009000100011 · DOI
  63. White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar. J., 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
  64. White, 2021, Anti-malarial drug effects on parasite dynamics in vivax malaria, Malar. J., 20, 161, 10.1186/s12936-021-03700-7 · DOI

Cited by

See all 3

Metadata

Authors
Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S.
Venue
iScience
Publisher
Elsevier BV
Published
2026-05
Volume
29
Issue
5
Pages
115799
ISSN
2589-0042
Cited by
3
References
1
Language
en
Licence
Funders
  • Institut Pasteur
  • Institut de Recherche pour le Développement
  • French National Research Agency (ANR-10-LABX-62-IBEID, ANR-16-CONV-0005)
  • Mackay Regional Council (MR/X020258/1)
  • Ahvaz Jundishapur University of Medical Sciences Infectious and Tropical Diseases Research Center (GNT1195236)
  • European Research Executive Agency
  • U.S. Public Health Service
  • National Institutes of Health
  • Australian Centre of Research Excellence in Malaria Elimination
  • Medical Research Council
  • Research Executive Agency
  • European Commission (101110393)
  • National Health and Medical Research Council (2016726)
  • National Institutes of Health Fogarty International Center (2D43TW007120-11A1)
  • Gates Foundation (OPP1151132)
  • National Institute of Allergy and Infectious Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification. https://app.cochat.ai/papers/10.1016/j.isci.2026.115799
The paper
Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S. (2026). Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification. iScience. https://doi.org/10.1016/j.isci.2026.115799

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.